Modulation of feeding through pharmacological targeting of the relaxin-3 receptor RXFP3 [ 2014 - 2017 ]

Research Grant

Researchers: Dr Karl Johan Rosengren (Principal investigator) ,  Dr Joseph Nicolazzo ,  Prof Andrew Gundlach ,  Prof Ross Bathgate

Brief description Relaxin-3 is a neuropeptide that regulates a number of physiological processes, including food intake, suggesting that the relaxin-3 receptor RXFP3 may be a new target for treatment of eating disorders such as obesity. This project will develop new selective and high-affinity ligands for RXFP3, which will be critical pharmacological tools for the preclinical studies and evaluation of this system.

Funding Amount $AUD 584,955.32

Funding Scheme Project Grants

Notes Standard Project Grant